Rubric Capital Management LP 13D and 13G filings for Collegium Pharmaceutical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:01 pm Purchase |
2024-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 2,350,000 7.290% |
1,100,000 (+88.00%) |
Filing |
| 2024-11-13 4:30 pm Sale |
2024-09-30 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 1,250,000 3.880% |
-1,508,253 (-54.68%) |
Filing |
| 2024-02-12 06:06 am Sale |
2023-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 2,758,253 8.460% |
-575,375 (-17.26%) |
Filing |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 3,333,628 9.930% |
727,128 (+27.90%) |
Filing |
| 2022-02-14 08:41 am Purchase |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 2,606,500 7.540% |
680,217 (+35.31%) |
Filing |
| 2021-02-16 08:25 am Purchase |
2020-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 1,926,283 5.570% |
1,926,283 (New Position) |
Filing |